Global Erdosteine Market Growth 2025-2031

October 2025 | 76 pages | ID: G7624BB1FA08EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Erdosteine market size is predicted to grow from US$ 89.2 million in 2025 to US$ 117 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Erdosteine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Erdosteine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Erdosteine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Erdosteine players cover Edmond Pharma, Alitair Pharmaceuticals, Zhejiang Kangle Pharmaceutical, Wuhan Yuancheng Pharmaceutical, Shanghai Pukang Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Erdosteine Industry Forecast” looks at past sales and reviews total world Erdosteine sales in 2024, providing a comprehensive analysis by region and market sector of projected Erdosteine sales for 2025 through 2031. With Erdosteine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erdosteine industry.

This Insight Report provides a comprehensive analysis of the global Erdosteine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erdosteine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Erdosteine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erdosteine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erdosteine.

This report presents a comprehensive overview, market shares, and growth opportunities of Erdosteine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Tablets
  • Capsules
Segmentation by Application:
  • Bronchitis
  • Nasopharyngitis
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Edmond Pharma
  • Alitair Pharmaceuticals
  • Zhejiang Kangle Pharmaceutical
  • Wuhan Yuancheng Pharmaceutical
  • Shanghai Pukang Pharmaceuticals
Key Questions Addressed in this Report

What is the 10-year outlook for the global Erdosteine market?
What factors are driving Erdosteine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erdosteine market opportunities vary by end market size?
How does Erdosteine break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Disposable Respirators Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Disposable Respirators by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Disposable Respirators by Country/Region, 2020, 2024 & 2031
2.2 Disposable Respirators Segment by Type
  2.2.1 N100
  2.2.2 N99
  2.2.3 N95
  2.2.4 P100
  2.2.5 P95
  2.2.6 R95
  2.2.7 Other
2.3 Disposable Respirators Sales by Type
  2.3.1 Global Disposable Respirators Sales Market Share by Type (2020-2025)
  2.3.2 Global Disposable Respirators Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Disposable Respirators Sale Price by Type (2020-2025)
2.4 Disposable Respirators Segment by Application
  2.4.1 Medical Industry
  2.4.2 Food Industry
  2.4.3 Agricultural
  2.4.4 Industrial
  2.4.5 Other
2.5 Disposable Respirators Sales by Application
  2.5.1 Global Disposable Respirators Sale Market Share by Application (2020-2025)
  2.5.2 Global Disposable Respirators Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Disposable Respirators Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Disposable Respirators Breakdown Data by Company
  3.1.1 Global Disposable Respirators Annual Sales by Company (2020-2025)
  3.1.2 Global Disposable Respirators Sales Market Share by Company (2020-2025)
3.2 Global Disposable Respirators Annual Revenue by Company (2020-2025)
  3.2.1 Global Disposable Respirators Revenue by Company (2020-2025)
  3.2.2 Global Disposable Respirators Revenue Market Share by Company (2020-2025)
3.3 Global Disposable Respirators Sale Price by Company
3.4 Key Manufacturers Disposable Respirators Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Disposable Respirators Product Location Distribution
  3.4.2 Players Disposable Respirators Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DISPOSABLE RESPIRATORS BY GEOGRAPHIC REGION

4.1 World Historic Disposable Respirators Market Size by Geographic Region (2020-2025)
  4.1.1 Global Disposable Respirators Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Disposable Respirators Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Disposable Respirators Market Size by Country/Region (2020-2025)
  4.2.1 Global Disposable Respirators Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Disposable Respirators Annual Revenue by Country/Region (2020-2025)
4.3 Americas Disposable Respirators Sales Growth
4.4 APAC Disposable Respirators Sales Growth
4.5 Europe Disposable Respirators Sales Growth
4.6 Middle East & Africa Disposable Respirators Sales Growth

5 AMERICAS

5.1 Americas Disposable Respirators Sales by Country
  5.1.1 Americas Disposable Respirators Sales by Country (2020-2025)
  5.1.2 Americas Disposable Respirators Revenue by Country (2020-2025)
5.2 Americas Disposable Respirators Sales by Type (2020-2025)
5.3 Americas Disposable Respirators Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Disposable Respirators Sales by Region
  6.1.1 APAC Disposable Respirators Sales by Region (2020-2025)
  6.1.2 APAC Disposable Respirators Revenue by Region (2020-2025)
6.2 APAC Disposable Respirators Sales by Type (2020-2025)
6.3 APAC Disposable Respirators Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Disposable Respirators by Country
  7.1.1 Europe Disposable Respirators Sales by Country (2020-2025)
  7.1.2 Europe Disposable Respirators Revenue by Country (2020-2025)
7.2 Europe Disposable Respirators Sales by Type (2020-2025)
7.3 Europe Disposable Respirators Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Disposable Respirators by Country
  8.1.1 Middle East & Africa Disposable Respirators Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Disposable Respirators Revenue by Country (2020-2025)
8.2 Middle East & Africa Disposable Respirators Sales by Type (2020-2025)
8.3 Middle East & Africa Disposable Respirators Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Disposable Respirators
10.3 Manufacturing Process Analysis of Disposable Respirators
10.4 Industry Chain Structure of Disposable Respirators

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Disposable Respirators Distributors
11.3 Disposable Respirators Customer

12 WORLD FORECAST REVIEW FOR DISPOSABLE RESPIRATORS BY GEOGRAPHIC REGION

12.1 Global Disposable Respirators Market Size Forecast by Region
  12.1.1 Global Disposable Respirators Forecast by Region (2026-2031)
  12.1.2 Global Disposable Respirators Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Disposable Respirators Forecast by Type (2026-2031)
12.7 Global Disposable Respirators Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 3M
  13.1.1 3M Company Information
  13.1.2 3M Disposable Respirators Product Portfolios and Specifications
  13.1.3 3M Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 3M Main Business Overview
  13.1.5 3M Latest Developments
13.2 Gerson
  13.2.1 Gerson Company Information
  13.2.2 Gerson Disposable Respirators Product Portfolios and Specifications
  13.2.3 Gerson Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Gerson Main Business Overview
  13.2.5 Gerson Latest Developments
13.3 Honeywell
  13.3.1 Honeywell Company Information
  13.3.2 Honeywell Disposable Respirators Product Portfolios and Specifications
  13.3.3 Honeywell Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Honeywell Main Business Overview
  13.3.5 Honeywell Latest Developments
13.4 Kimberly-Clark
  13.4.1 Kimberly-Clark Company Information
  13.4.2 Kimberly-Clark Disposable Respirators Product Portfolios and Specifications
  13.4.3 Kimberly-Clark Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Kimberly-Clark Main Business Overview
  13.4.5 Kimberly-Clark Latest Developments
13.5 Moldex
  13.5.1 Moldex Company Information
  13.5.2 Moldex Disposable Respirators Product Portfolios and Specifications
  13.5.3 Moldex Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Moldex Main Business Overview
  13.5.5 Moldex Latest Developments
13.6 Filter Service
  13.6.1 Filter Service Company Information
  13.6.2 Filter Service Disposable Respirators Product Portfolios and Specifications
  13.6.3 Filter Service Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Filter Service Main Business Overview
  13.6.5 Filter Service Latest Developments
13.7 BioClean
  13.7.1 BioClean Company Information
  13.7.2 BioClean Disposable Respirators Product Portfolios and Specifications
  13.7.3 BioClean Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 BioClean Main Business Overview
  13.7.5 BioClean Latest Developments
13.8 UVEX
  13.8.1 UVEX Company Information
  13.8.2 UVEX Disposable Respirators Product Portfolios and Specifications
  13.8.3 UVEX Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 UVEX Main Business Overview
  13.8.5 UVEX Latest Developments
13.9 Drager Safety
  13.9.1 Drager Safety Company Information
  13.9.2 Drager Safety Disposable Respirators Product Portfolios and Specifications
  13.9.3 Drager Safety Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Drager Safety Main Business Overview
  13.9.5 Drager Safety Latest Developments
13.10 Fido Masks Co., Ltd
  13.10.1 Fido Masks Co., Ltd Company Information
  13.10.2 Fido Masks Co., Ltd Disposable Respirators Product Portfolios and Specifications
  13.10.3 Fido Masks Co., Ltd Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Fido Masks Co., Ltd Main Business Overview
  13.10.5 Fido Masks Co., Ltd Latest Developments
13.11 Ho Cheng Enterprise
  13.11.1 Ho Cheng Enterprise Company Information
  13.11.2 Ho Cheng Enterprise Disposable Respirators Product Portfolios and Specifications
  13.11.3 Ho Cheng Enterprise Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Ho Cheng Enterprise Main Business Overview
  13.11.5 Ho Cheng Enterprise Latest Developments
13.12 Miller
  13.12.1 Miller Company Information
  13.12.2 Miller Disposable Respirators Product Portfolios and Specifications
  13.12.3 Miller Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Miller Main Business Overview
  13.12.5 Miller Latest Developments
13.13 Condor Protective Gear
  13.13.1 Condor Protective Gear Company Information
  13.13.2 Condor Protective Gear Disposable Respirators Product Portfolios and Specifications
  13.13.3 Condor Protective Gear Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Condor Protective Gear Main Business Overview
  13.13.5 Condor Protective Gear Latest Developments
13.14 Hospeco
  13.14.1 Hospeco Company Information
  13.14.2 Hospeco Disposable Respirators Product Portfolios and Specifications
  13.14.3 Hospeco Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Hospeco Main Business Overview
  13.14.5 Hospeco Latest Developments
13.15 Impact
  13.15.1 Impact Company Information
  13.15.2 Impact Disposable Respirators Product Portfolios and Specifications
  13.15.3 Impact Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 Impact Main Business Overview
  13.15.5 Impact Latest Developments
13.16 SAS Safety Corp
  13.16.1 SAS Safety Corp Company Information
  13.16.2 SAS Safety Corp Disposable Respirators Product Portfolios and Specifications
  13.16.3 SAS Safety Corp Disposable Respirators Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 SAS Safety Corp Main Business Overview
  13.16.5 SAS Safety Corp Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Erdosteine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Erdosteine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Erdosteine Sales by Type (2020-2025) & (K Doses)
Table 6. Global Erdosteine Sales Market Share by Type (2020-2025)
Table 7. Global Erdosteine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Erdosteine Revenue Market Share by Type (2020-2025)
Table 9. Global Erdosteine Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Erdosteine Sale by Application (2020-2025) & (K Doses)
Table 11. Global Erdosteine Sale Market Share by Application (2020-2025)
Table 12. Global Erdosteine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Erdosteine Revenue Market Share by Application (2020-2025)
Table 14. Global Erdosteine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Erdosteine Sales by Company (2020-2025) & (K Doses)
Table 16. Global Erdosteine Sales Market Share by Company (2020-2025)
Table 17. Global Erdosteine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Erdosteine Revenue Market Share by Company (2020-2025)
Table 19. Global Erdosteine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Erdosteine Producing Area Distribution and Sales Area
Table 21. Players Erdosteine Products Offered
Table 22. Erdosteine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Erdosteine Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Erdosteine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Erdosteine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Erdosteine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Erdosteine Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Erdosteine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Erdosteine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Erdosteine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Erdosteine Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Erdosteine Sales Market Share by Country (2020-2025)
Table 35. Americas Erdosteine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Erdosteine Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Erdosteine Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Erdosteine Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Erdosteine Sales Market Share by Region (2020-2025)
Table 40. APAC Erdosteine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Erdosteine Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Erdosteine Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Erdosteine Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Erdosteine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Erdosteine Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Erdosteine Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Erdosteine Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Erdosteine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Erdosteine Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Erdosteine Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Erdosteine
Table 52. Key Market Challenges & Risks of Erdosteine
Table 53. Key Industry Trends of Erdosteine
Table 54. Erdosteine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Erdosteine Distributors List
Table 57. Erdosteine Customer List
Table 58. Global Erdosteine Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Erdosteine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Erdosteine Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Erdosteine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Erdosteine Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Erdosteine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Erdosteine Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Erdosteine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Erdosteine Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Erdosteine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Erdosteine Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Erdosteine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Erdosteine Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Erdosteine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Edmond Pharma Basic Information, Erdosteine Manufacturing Base, Sales Area and Its Competitors
Table 73. Edmond Pharma Erdosteine Product Portfolios and Specifications
Table 74. Edmond Pharma Erdosteine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Edmond Pharma Main Business
Table 76. Edmond Pharma Latest Developments
Table 77. Alitair Pharmaceuticals Basic Information, Erdosteine Manufacturing Base, Sales Area and Its Competitors
Table 78. Alitair Pharmaceuticals Erdosteine Product Portfolios and Specifications
Table 79. Alitair Pharmaceuticals Erdosteine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Alitair Pharmaceuticals Main Business
Table 81. Alitair Pharmaceuticals Latest Developments
Table 82. Zhejiang Kangle Pharmaceutical Basic Information, Erdosteine Manufacturing Base, Sales Area and Its Competitors
Table 83. Zhejiang Kangle Pharmaceutical Erdosteine Product Portfolios and Specifications
Table 84. Zhejiang Kangle Pharmaceutical Erdosteine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Zhejiang Kangle Pharmaceutical Main Business
Table 86. Zhejiang Kangle Pharmaceutical Latest Developments
Table 87. Wuhan Yuancheng Pharmaceutical Basic Information, Erdosteine Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Yuancheng Pharmaceutical Erdosteine Product Portfolios and Specifications
Table 89. Wuhan Yuancheng Pharmaceutical Erdosteine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Wuhan Yuancheng Pharmaceutical Main Business
Table 91. Wuhan Yuancheng Pharmaceutical Latest Developments
Table 92. Shanghai Pukang Pharmaceuticals Basic Information, Erdosteine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Pukang Pharmaceuticals Erdosteine Product Portfolios and Specifications
Table 94. Shanghai Pukang Pharmaceuticals Erdosteine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Shanghai Pukang Pharmaceuticals Main Business
Table 96. Shanghai Pukang Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Erdosteine
Figure 2. Erdosteine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Erdosteine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Erdosteine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Erdosteine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Erdosteine Sales Market Share by Country/Region (2024)
Figure 10. Erdosteine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Erdosteine Sales Market Share by Type in 2025
Figure 14. Global Erdosteine Revenue Market Share by Type (2020-2025)
Figure 15. Erdosteine Consumed in Bronchitis
Figure 16. Global Erdosteine Market: Bronchitis (2020-2025) & (K Doses)
Figure 17. Erdosteine Consumed in Nasopharyngitis
Figure 18. Global Erdosteine Market: Nasopharyngitis (2020-2025) & (K Doses)
Figure 19. Erdosteine Consumed in Others
Figure 20. Global Erdosteine Market: Others (2020-2025) & (K Doses)
Figure 21. Global Erdosteine Sale Market Share by Application (2024)
Figure 22. Global Erdosteine Revenue Market Share by Application in 2025
Figure 23. Erdosteine Sales by Company in 2025 (K Doses)
Figure 24. Global Erdosteine Sales Market Share by Company in 2025
Figure 25. Erdosteine Revenue by Company in 2025 ($ millions)
Figure 26. Global Erdosteine Revenue Market Share by Company in 2025
Figure 27. Global Erdosteine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Erdosteine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Erdosteine Sales 2020-2025 (K Doses)
Figure 30. Americas Erdosteine Revenue 2020-2025 ($ millions)
Figure 31. APAC Erdosteine Sales 2020-2025 (K Doses)
Figure 32. APAC Erdosteine Revenue 2020-2025 ($ millions)
Figure 33. Europe Erdosteine Sales 2020-2025 (K Doses)
Figure 34. Europe Erdosteine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Erdosteine Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Erdosteine Revenue 2020-2025 ($ millions)
Figure 37. Americas Erdosteine Sales Market Share by Country in 2025
Figure 38. Americas Erdosteine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Erdosteine Sales Market Share by Type (2020-2025)
Figure 40. Americas Erdosteine Sales Market Share by Application (2020-2025)
Figure 41. United States Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Erdosteine Sales Market Share by Region in 2025
Figure 46. APAC Erdosteine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Erdosteine Sales Market Share by Type (2020-2025)
Figure 48. APAC Erdosteine Sales Market Share by Application (2020-2025)
Figure 49. China Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Erdosteine Sales Market Share by Country in 2025
Figure 57. Europe Erdosteine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Erdosteine Sales Market Share by Type (2020-2025)
Figure 59. Europe Erdosteine Sales Market Share by Application (2020-2025)
Figure 60. Germany Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Erdosteine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Erdosteine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Erdosteine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Erdosteine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Erdosteine in 2025
Figure 74. Manufacturing Process Analysis of Erdosteine
Figure 75. Industry Chain Structure of Erdosteine
Figure 76. Channels of Distribution
Figure 77. Global Erdosteine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Erdosteine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Erdosteine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Erdosteine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Erdosteine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Erdosteine Revenue Market Share Forecast by Application (2026-2031)


More Publications